Gahart’s 2018 Intravenous Medications

1444 Pages·2017·9.84 MB·English

by  Betty L. Gahart

Get more medical books and resources at
www.medicalbr.tk
Gahart’s 2018
INTRAVENOUS
MEDICATIONS
A Handbook for Nurses and Health Professionals
BETTY L. GAHART, RN
Nurse Consultant in Education
Napa, California
Former Director, Education and Training
Queen of the Valley Medical Center
Napa, California
ADRIENNE R. NAZARENO, PharmD
Clinical Manager, Department of Pharmacy
Queen of the Valley Medical Center
Napa, California
MEGHAN Q. ORTEGA, RN, BSN
Staff Nurse
Clovis Community Medical Center
Clovis, California
THIRTY-FOURTH EDITION
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
General Dilution Chart (Gm to mg)
Amount of Diluent
Amount of Drug
Required in Grams 1,000 mL 500 mL 250 mL 125 mL 100 mL 50 mL 25 mL
mg/mL mg/mL mg/mL mg/mL mg/mL mg/mL mg/mL
20 Gm 20 40 80 160 200 400 800
19 Gm 19 38 76 152 190 380 760
18 Gm 18 36 72 144 180 360 720
17 Gm 17 34 68 136 170 340 680
16 Gm 16 32 64 128 160 320 640
15 Gm 15 30 60 120 150 300 600
14 Gm 14 28 56 112 140 280 560
13 Gm 13 26 52 104 130 260 520
12 Gm 12 24 48 96 120 240 480
11 Gm 11 22 44 88 110 220 440
10 Gm 10 20 40 80 100 200 400
9 Gm 9 18 36 72 90 180 360
8 Gm 8 16 32 64 80 160 320
7 Gm 7 14 28 56 70 140 280
6 Gm 6 12 24 48 60 120 240
5 Gm 5 10 20 40 50 100 200
4.5 Gm 4.5 9 18 36 45 90 180
4 Gm 4 8 16 32 40 80 160
3.5 Gm 3.5 7 14 28 35 70 140
3 Gm 3 6 12 24 30 60 120
2.5 Gm 2.5 5 10 20 25 50 100
2 Gm 2 4 8 16 20 40 80
1.5 Gm 1.5 3 6 12 15 30 60
1 Gm 1 2 4 8 10 20 40
0.5 Gm 0.5 1 2 4 5 10 20
0.25 Gm 0.25 0.5 1 2 2.5 5 10
To use chart:
1. Find mg/mL desired, track to amount of diluent desired and amount of drug in Grams
required.
2. Find amount of drug in Grams required, track to diluent desired and/or mg/mL
desired.
3. Find amount of diluent required, track to amount of drug in Grams and/or mg/mL
desired.
Formula: Substitute any number for X
X Grams diluted in 1,000 mL 5 X mg/mL (1 Gram in 1,000 mL 5 1 mg/mL)
X Grams diluted in 500 mL 5 2 X mg/mL (1 Gram in 500 mL 5 2 mg/mL)
X Grams diluted in 250 mL 5 4 X mg/mL (1 Gram in 250 mL 5 4 mg/mL)
X Grams diluted in 125 mL 5 8 X mg/mL (1 Gram in 125 ml 5 8 mg/mL)
X Grams diluted in 100 mL 5 10 X mg/mL (1 Gram in 100 mL 5 10 mg/mL)
X Grams diluted in 50 mL 5 20 X mg/mL (1 Gram in 50 mL 5 20 mg/mL)
X Grams diluted in 25 mL 5 40 X mg/mL (1 Gram in 25 mL 5 40 mg/mL)
Some variation occurs from manufacturer’s overfill or if the drug is in liquid form. If
absolute accuracy is required, these variations can be avoided by withdrawing an amount
in mL from the diluent equal to manufacturer’s overfill and/or an amount equal to the
amount in mL of the drug. Consult the pharmacist for specific information on manufac-
turer’s overfill of infusion fluids used in your facility.
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
General Dilution Chart (mg to mcg)
Amount of Diluent
Amount of Drug
Required in Grams 1,000 mL 500 mL 250 mL 125 mL 100 mL 50 mL 25 mL
mcg/mL mcg/mL mcg/mL mcg/mL mcg/mL mcg/mL mcg/mL
20 mg 20 40 80 160 200 400 800
19 mg 19 38 76 152 190 380 760
18 mg 18 36 72 144 180 360 720
17 mg 17 34 68 136 170 340 680
16 mg 16 32 64 128 160 320 640
15 mg 15 30 60 120 150 300 600
14 mg 14 28 56 112 140 280 560
13 mg 13 26 52 104 130 260 520
12 mg 12 24 48 96 120 240 480
11 mg 11 22 44 88 110 220 440
10 mg 10 20 40 80 100 200 400
9 mg 9 18 36 72 90 180 360
8 mg 8 16 32 64 80 160 320
7 mg 7 14 28 56 70 140 280
6 mg 6 12 24 48 60 120 240
5 mg 5 10 20 40 50 100 200
4.5 mg 4.5 9 18 36 45 90 180
4 mg 4 8 16 32 40 80 160
3.5 mg 3.5 7 14 28 35 70 140
3 mg 3 6 12 24 30 60 120
2.5 mg 2.5 5 10 20 25 50 100
2 mg 2 4 8 16 20 40 80
1.5 mg 1.5 3 6 12 15 30 60
1 mg 1 2 4 8 10 20 40
0.5 mg 0.5 1 2 4 5 10 20
0.25 mg 0.25 0.5 1 2 2.5 5 10
To use chart:
1. Find mcg/mL desired, track to amount of diluent desired and amount of drug in mg
required.
2. Find amount of drug in mg required, track to diluent desired and/or mcg/mL desired.
3. Find amount of diluent required, track to amount of drug in mg and/or mcg/mL desired.
Formula: Substitute any number for X
X mg diluted in 1,000 mL 5 X mcg/mL (1 mg in 1,000 mL 5 1 mcg/mL)
X mg diluted in 500 mL 5 2 X mcg/mL (1 mg in 500 mL 5 2 mcg/mL)
X mg diluted in 250 mL 5 4 X mcg/mL (1 mg in 250 mL 5 4 mcg/mL)
X mg diluted in 125 mL 5 8 X mcg/mL (1 mg in 125 ml 5 8 mcg/mL)
X mg diluted in 100 mL 5 10 X mcg/mL (1 mg in 100 mL 5 10 mcg/mL)
X mg diluted in 50 mL 5 20 X mcg/mL (1 mg in 50 mL 5 20 mcg/mL)
X mg diluted in 25 mL 5 40 X mcg/mL (1 mg in 25 mL 5 40 mcg/mL)
Some variation occurs from manufacturer’s overfill or if the drug is in liquid form. If
absolute accuracy is required, these variations can be avoided by withdrawing an amount
in mL from the diluent equal to manufacturer’s overfill and/or an amount equal to the
amount in mL of the drug. Consult the pharmacist for specific information on manufac-
turer’s overfill of infusion fluids used in your facility.
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
HOW TO USE THIS BOOK
STEP 1
Refer to the index at the back of the book. You can find any drug by any name in less than
5 seconds. All drugs are cross-indexed by generic and all known trade names. The index
is easily distinguished by a printed blue bar at the edge of the pages. Drugs are also in-
dexed by pharmacologic action. With one turn of the page, all drugs included in the text
with similar pharmacologic actions and their page numbers are available to you. Every-
thing is strictly alphabetized; you will never be required to refer to additional pages to
locate a drug.
STEP 2
Turn to the single page number given after the name of the drug. All information about
the drug is included as continuous reading. You will rarely be required to turn to another
section of the book to be completely informed. Specific breakdowns of each drug (Usual
Dose, Pediatric Dose, Dose Adjustments, Dilution, Compatibility, Rate of Administra-
tion, Actions, Indications and Uses, Precautions, Contraindications, Drug/Lab Interac-
tions, Side Effects, and Antidote) are consistent in format and printed in boldface type.
Subheadings under these categories are in boldface. Scan quickly for a Usual Dose
check, Dose Adjustment, Drug/Lab Interaction, Side Effect, or Antidote or carefully read
all included information. The choice is yours. A quick scan will take 5 to 10 seconds.
Even the most complicated drugs will take less than 2 minutes to read completely. Read
each monograph carefully and completely before administering a drug to a specific pa-
tient for the first time and review it any time a new drug is added to the patient’s drug
profile.
That’s it! A fast, complete, and accurate reference for anyone administering intravenous
medications. The spiral binding is specifically designed to lie flat, leaving your hands
free to secure needed supplies, prepare your medication, or even ventilate a patient while
you read the needed information.
Develop the “look it up” habit. Clear, concise language and simplicity of form con-
tribute to quick, easy use of this handbook. Before your first use, read the preface; it
contains lots of helpful information.
Check out the Intravenous Medications website for monographs no longer included in
this text and for other useful IV medication information:
http://evolve.elsevier.com/IVMeds
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
3251 Riverport Lane
St. Louis, Missouri 63043
INTRAVENOUS MEDICATIONS ISBN: 978-0-323-29740-0
Copyright © 2018 by Elsevier Inc. All rights reserved.
No part of this publication may be reproduced or transmitted in any form or by any means,
electronic or mechanical, including photocopying, recording, or any information storage
and retrieval system, without permission in writing from the publisher. Details on how to
seek permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the Copyright
Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the
Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional
practices, or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge
in evaluating and using any information, methods, compounds, or experiments described
herein. In using such information or methods they should be mindful of their own safety
and the safety of others, including parties for whom they have a professional responsibility.
With respect to any drug or pharmaceutical products identified, readers are advised to
check the most current information provided (i) on procedures featured or (ii) by the
manufacturer of each product to be administered, to verify the recommended dose or
formula, the method and duration of administration, and contraindications. It is the
responsibility of the practitioners, relying on their own experience and knowledge of their
patients, to make diagnoses, to determine dosages and the best treatment for each
individual patient, and to take all appropriate safety precautions.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or
editors, assume any liability for any injury and/or damage to persons or property as a
matter of products liability, negligence or otherwise, or from any use or operation of any
methods, products, instructions, or ideas contained in the material herein.
Previous editions copyrighted 1973, 1977, 1981, 1984, 1988, 1989, 1990, 1991, 1993, 1994,
1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008,
2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017
ISBN: 978-0-323-29740-0
ISSN: 1556-7443
Executive Content Strategist: Sonya Seigafuse
Senior Content Development Specialist: Billie C. Sharp; Tina Kaemmerer
Publishing Services Manager: Jeff Patterson
Senior Project Manager: Jodi M. Willard
Design Direction: Ryan Cook
Printed in the United States of America
Last digit is the print number: 9 8 7 6 5 4 3 2 1
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
To my husband,
Bill,
for his patience, support, and many hours of much-
needed and appreciated assistance, and to our children,
Marty, Jeff, Debbie, Rick, and Teresa;
their spouses, Sally, Terri, Jim, and Bill;
and our grandchildren, Meghan, Laurie, Alex, Anne,
Kathryn, Lisa, Benjamin, Matthew, Claire, Neil, Scott, and Alan,
for their encouragement and understanding.
BLG
To my husband,
Greg,
for his loving support and encouragement, and to my children,
Danielle, Bryan, Emily, and Mark, for allowing me the freedom
to pursue my professional practice.
ARN
To my husband,
Nate,
as well as my parents, Jim and Debbie,
for their unconditional love, support, and understanding.
To my grandparents Bill and Betty for their wisdom and guidance.
Lastly, to God, for His grace and for paving my path.
MQO
Downloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
NURSING AND PHARMACOLOGY CONSULTANTS
KIM HUBER, PharmD MERRILEE NEWTON, RN, MSN
Clinical Pharmacist Administrative Director of Quality and
Memorial Medical Center Infection Prevention—Retired
Modesto, California Alta Bates Summit Medical Center
Berkeley, California
GREGORY D. NAZARENO, PharmD
Staff Pharmacist
John Muir Medical Center
Walnut Creek, California
REVIEWERS
DANA H. HAMAMURA, PharmD, RPh RANDOLPH E. REGAL, BS, PharmD
Clinical Pharmacist Clinical Associate Professor
Emergency Department Adult Internal Medicine
University of Colorado Hospital University of Michigan Hospital and
Aurora, Colorado College of Pharmacy
Ann Arbor, Michigan
JOSHUA J. NEUMILLER, PharmD, CDE, FASCP
Assistant Professor of Pharmacotherapy TRAVIS E. SONNETT, PharmD, FASCP
College of Pharmacy Clinical Pharmacy Specialist
Washington State University Mann-Grandstaff VA Medical Center;
Spokane, Washington Clinical Assistant Professor
College of Pharmacy
CHRISTOPHER T. OWENS, PharmD, MPH Washington State University
Associate Professor and Chair Spokane, Washington
Department of Pharmacy Practice and
Administrative Sciences
Idaho State University College of Pharmacy
Pocatello, Idaho
Dovwiiniloaded for Jeon Su-tae ([email protected]) at KESLI - Korea University Central library from ClinicalKey.com by Elsevier on
August 10, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.